nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—type 2 diabetes mellitus—coronary artery disease	0.212	1	CtDrD
Nateglinide—Enalapril—coronary artery disease	0.0802	0.282	CrCtD
Nateglinide—Trandolapril—coronary artery disease	0.0802	0.282	CrCtD
Nateglinide—Lisinopril—coronary artery disease	0.0628	0.221	CrCtD
Nateglinide—Ramipril—coronary artery disease	0.0608	0.214	CrCtD
Nateglinide—PPARG—coronary artery disease	0.0477	0.727	CbGaD
Nateglinide—ALB—coronary artery disease	0.0179	0.273	CbGaD
Nateglinide—Enalapril—Captopril—coronary artery disease	0.0138	0.073	CrCrCtD
Nateglinide—PPARG—Telmisartan—coronary artery disease	0.0122	0.0678	CbGbCtD
Nateglinide—SLC16A1—Niacin—coronary artery disease	0.0112	0.0621	CbGbCtD
Nateglinide—SLC16A1—Pravastatin—coronary artery disease	0.00863	0.048	CbGbCtD
Nateglinide—Spirapril—Perindopril—coronary artery disease	0.00792	0.042	CrCrCtD
Nateglinide—Cilazapril—Perindopril—coronary artery disease	0.00792	0.042	CrCrCtD
Nateglinide—Ramipril—Perindopril—coronary artery disease	0.00743	0.0394	CrCrCtD
Nateglinide—Trandolapril—Perindopril—coronary artery disease	0.00743	0.0394	CrCrCtD
Nateglinide—Enalapril—Perindopril—coronary artery disease	0.00743	0.0394	CrCrCtD
Nateglinide—Mitiglinide—Trandolapril—coronary artery disease	0.00716	0.038	CrCrCtD
Nateglinide—SLC15A2—Trandolapril—coronary artery disease	0.0071	0.0395	CbGbCtD
Nateglinide—SLC15A2—Perindopril—coronary artery disease	0.00649	0.0361	CbGbCtD
Nateglinide—ORM1—Penbutolol—coronary artery disease	0.00624	0.0347	CbGbCtD
Nateglinide—Cilazapril—Trandolapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—Lisinopril—Trandolapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—Cilazapril—Enalapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—Lisinopril—Enalapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—Spirapril—Trandolapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—Spirapril—Enalapril—coronary artery disease	0.00618	0.0328	CrCrCtD
Nateglinide—SLC15A1—Trandolapril—coronary artery disease	0.00611	0.034	CbGbCtD
Nateglinide—Trandolapril—Enalapril—coronary artery disease	0.0058	0.0308	CrCrCtD
Nateglinide—Enalapril—Trandolapril—coronary artery disease	0.0058	0.0308	CrCrCtD
Nateglinide—Ramipril—Enalapril—coronary artery disease	0.0058	0.0308	CrCrCtD
Nateglinide—Ramipril—Trandolapril—coronary artery disease	0.0058	0.0308	CrCrCtD
Nateglinide—SLC15A1—Perindopril—coronary artery disease	0.00559	0.0311	CbGbCtD
Nateglinide—ORM1—Pitavastatin—coronary artery disease	0.00545	0.0303	CbGbCtD
Nateglinide—Mitiglinide—Ramipril—coronary artery disease	0.00542	0.0288	CrCrCtD
Nateglinide—SLC15A2—Ramipril—coronary artery disease	0.00538	0.0299	CbGbCtD
Nateglinide—Aspartame—Trandolapril—coronary artery disease	0.00491	0.0261	CrCrCtD
Nateglinide—Aspartame—Enalapril—coronary artery disease	0.00491	0.0261	CrCrCtD
Nateglinide—Cilazapril—Lisinopril—coronary artery disease	0.00484	0.0257	CrCrCtD
Nateglinide—Spirapril—Lisinopril—coronary artery disease	0.00484	0.0257	CrCrCtD
Nateglinide—Spirapril—Ramipril—coronary artery disease	0.00469	0.0249	CrCrCtD
Nateglinide—Lisinopril—Ramipril—coronary artery disease	0.00469	0.0249	CrCrCtD
Nateglinide—Cilazapril—Ramipril—coronary artery disease	0.00469	0.0249	CrCrCtD
Nateglinide—SLC15A1—Enalapril—coronary artery disease	0.00463	0.0258	CbGbCtD
Nateglinide—SLC15A1—Ramipril—coronary artery disease	0.00463	0.0258	CbGbCtD
Nateglinide—SLC15A1—Lisinopril—coronary artery disease	0.00463	0.0258	CbGbCtD
Nateglinide—ABCC4—Rosuvastatin—coronary artery disease	0.00456	0.0254	CbGbCtD
Nateglinide—Enalapril—Lisinopril—coronary artery disease	0.00454	0.0241	CrCrCtD
Nateglinide—Trandolapril—Lisinopril—coronary artery disease	0.00454	0.0241	CrCrCtD
Nateglinide—Ramipril—Lisinopril—coronary artery disease	0.00454	0.0241	CrCrCtD
Nateglinide—Trandolapril—Ramipril—coronary artery disease	0.0044	0.0233	CrCrCtD
Nateglinide—Enalapril—Ramipril—coronary artery disease	0.0044	0.0233	CrCrCtD
Nateglinide—Aspartame—Lisinopril—coronary artery disease	0.00384	0.0204	CrCrCtD
Nateglinide—ABCC4—Atorvastatin—coronary artery disease	0.00378	0.021	CbGbCtD
Nateglinide—Aspartame—Ramipril—coronary artery disease	0.00372	0.0198	CrCrCtD
Nateglinide—SLC15A1—Captopril—coronary artery disease	0.00347	0.0193	CbGbCtD
Nateglinide—CYP3A7—Eplerenone—coronary artery disease	0.00261	0.0145	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.00261	0.0145	CbGbCtD
Nateglinide—SLC22A6—Enalapril—coronary artery disease	0.00255	0.0142	CbGbCtD
Nateglinide—ALB—Pitavastatin—coronary artery disease	0.00229	0.0128	CbGbCtD
Nateglinide—ALB—Valsartan—coronary artery disease	0.00223	0.0124	CbGbCtD
Nateglinide—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00221	0.0123	CbGbCtD
Nateglinide—CYP3A5—Clopidogrel—coronary artery disease	0.00211	0.0117	CbGbCtD
Nateglinide—CYP2C9—Fenofibrate—coronary artery disease	0.00204	0.0113	CbGbCtD
Nateglinide—CYP3A5—Eplerenone—coronary artery disease	0.00196	0.0109	CbGbCtD
Nateglinide—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.00193	0.0108	CbGbCtD
Nateglinide—SLC22A6—Captopril—coronary artery disease	0.00191	0.0106	CbGbCtD
Nateglinide—SLC22A6—Pravastatin—coronary artery disease	0.00181	0.01	CbGbCtD
Nateglinide—ALB—Rosuvastatin—coronary artery disease	0.00169	0.0094	CbGbCtD
Nateglinide—CYP3A7—Simvastatin—coronary artery disease	0.00168	0.00936	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00168	0.00936	CbGbCtD
Nateglinide—CYP3A7—Lovastatin—coronary artery disease	0.00165	0.00916	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00165	0.00916	CbGbCtD
Nateglinide—ALB—Acetylsalicylic acid—coronary artery disease	0.00165	0.00916	CbGbCtD
Nateglinide—CYP2C9—Gemfibrozil—coronary artery disease	0.00163	0.00907	CbGbCtD
Nateglinide—ALB—Captopril—coronary artery disease	0.00163	0.00905	CbGbCtD
Nateglinide—SLC22A6—Furosemide—coronary artery disease	0.00154	0.00854	CbGbCtD
Nateglinide—SLC22A6—Losartan—coronary artery disease	0.0015	0.00837	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0015	0.00835	CbGbCtD
Nateglinide—CYP3A7—Atorvastatin—coronary artery disease	0.0015	0.00835	CbGbCtD
Nateglinide—CYP2C9—Clopidogrel—coronary artery disease	0.00141	0.00786	CbGbCtD
Nateglinide—CYP3A5—Rosuvastatin—coronary artery disease	0.00136	0.00756	CbGbCtD
Nateglinide—CYP3A4—Ticagrelor—coronary artery disease	0.00133	0.0074	CbGbCtD
Nateglinide—ALB—Furosemide—coronary artery disease	0.00131	0.00727	CbGbCtD
Nateglinide—ALB—Losartan—coronary artery disease	0.00128	0.00712	CbGbCtD
Nateglinide—CYP3A5—Simvastatin—coronary artery disease	0.00126	0.00702	CbGbCtD
Nateglinide—CYP3A5—Pravastatin—coronary artery disease	0.00124	0.00687	CbGbCtD
Nateglinide—CYP3A5—Lovastatin—coronary artery disease	0.00124	0.00687	CbGbCtD
Nateglinide—CYP2C9—Pitavastatin—coronary artery disease	0.00124	0.00687	CbGbCtD
Nateglinide—CYP2C9—Valsartan—coronary artery disease	0.0012	0.00669	CbGbCtD
Nateglinide—CYP3A4—Fenofibrate—coronary artery disease	0.00119	0.0066	CbGbCtD
Nateglinide—CYP3A5—Atorvastatin—coronary artery disease	0.00113	0.00626	CbGbCtD
Nateglinide—CYP3A5—Losartan—coronary artery disease	0.00103	0.00573	CbGbCtD
Nateglinide—CYP2C9—cardial valve—coronary artery disease	0.00102	0.238	CbGeAlD
Nateglinide—CYP2D6—Niacin—coronary artery disease	0.00098	0.00545	CbGbCtD
Nateglinide—CYP3A4—Gemfibrozil—coronary artery disease	0.000948	0.00527	CbGbCtD
Nateglinide—CYP2C9—Rosuvastatin—coronary artery disease	0.000911	0.00507	CbGbCtD
Nateglinide—CYP2D6—Timolol—coronary artery disease	0.000911	0.00507	CbGbCtD
Nateglinide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.000888	0.00494	CbGbCtD
Nateglinide—CYP2C9—Simvastatin—coronary artery disease	0.000847	0.00471	CbGbCtD
Nateglinide—CYP2C9—Pravastatin—coronary artery disease	0.000829	0.00461	CbGbCtD
Nateglinide—CYP2C9—Lovastatin—coronary artery disease	0.000829	0.00461	CbGbCtD
Nateglinide—CYP3A4—Clopidogrel—coronary artery disease	0.000822	0.00457	CbGbCtD
Nateglinide—CYP2D6—Captopril—coronary artery disease	0.000802	0.00446	CbGbCtD
Nateglinide—CYP2D6—Simvastatin—coronary artery disease	0.000775	0.00431	CbGbCtD
Nateglinide—CYP3A4—Eplerenone—coronary artery disease	0.000764	0.00425	CbGbCtD
Nateglinide—CYP2D6—Lovastatin—coronary artery disease	0.000758	0.00422	CbGbCtD
Nateglinide—CYP2D6—Pravastatin—coronary artery disease	0.000758	0.00422	CbGbCtD
Nateglinide—CYP2C9—Atorvastatin—coronary artery disease	0.000755	0.0042	CbGbCtD
Nateglinide—CYP2C9—Losartan—coronary artery disease	0.000691	0.00384	CbGbCtD
Nateglinide—CYP2D6—Atorvastatin—coronary artery disease	0.00069	0.00384	CbGbCtD
Nateglinide—CYP3A4—Enalapril—coronary artery disease	0.000681	0.00379	CbGbCtD
Nateglinide—CYP3A4—Rosuvastatin—coronary artery disease	0.00053	0.00295	CbGbCtD
Nateglinide—CYP3A4—Ezetimibe—coronary artery disease	0.00053	0.00295	CbGbCtD
Nateglinide—CYP3A4—Simvastatin—coronary artery disease	0.000493	0.00274	CbGbCtD
Nateglinide—CYP3A4—Lovastatin—coronary artery disease	0.000482	0.00268	CbGbCtD
Nateglinide—CYP3A4—Pravastatin—coronary artery disease	0.000482	0.00268	CbGbCtD
Nateglinide—CYP3A4—Atorvastatin—coronary artery disease	0.000439	0.00244	CbGbCtD
Nateglinide—CYP3A4—Losartan—coronary artery disease	0.000402	0.00223	CbGbCtD
Nateglinide—Bortezomib—PSMB5—coronary artery disease	0.000389	0.335	CrCbGaD
Nateglinide—PPARG—artery—coronary artery disease	0.000261	0.0609	CbGeAlD
Nateglinide—Lisinopril—ACE2—coronary artery disease	0.000229	0.197	CrCbGaD
Nateglinide—PPARG—endothelium—coronary artery disease	0.00022	0.0514	CbGeAlD
Nateglinide—SLC16A1—cardiac ventricle—coronary artery disease	0.000174	0.0407	CbGeAlD
Nateglinide—SLC16A1—myocardium—coronary artery disease	0.000164	0.0383	CbGeAlD
Nateglinide—PTGS1—artery—coronary artery disease	0.000139	0.0325	CbGeAlD
Nateglinide—PPARG—myocardium—coronary artery disease	0.000138	0.0321	CbGeAlD
Nateglinide—KCNJ11—heart—coronary artery disease	0.000137	0.0319	CbGeAlD
Nateglinide—KCNJ11—cardiovascular system—coronary artery disease	0.000129	0.0301	CbGeAlD
Nateglinide—ABCC8—heart—coronary artery disease	0.000126	0.0294	CbGeAlD
Nateglinide—ABCC8—cardiovascular system—coronary artery disease	0.000119	0.0277	CbGeAlD
Nateglinide—PTGS1—endothelium—coronary artery disease	0.000118	0.0275	CbGeAlD
Nateglinide—SLC16A1—heart—coronary artery disease	0.000114	0.0267	CbGeAlD
Nateglinide—SLC16A1—cardiovascular system—coronary artery disease	0.000108	0.0252	CbGeAlD
Nateglinide—SLC16A1—cardiac atrium—coronary artery disease	9.79e-05	0.0228	CbGeAlD
Nateglinide—Lacosamide—CA5B—coronary artery disease	9.63e-05	0.0829	CrCbGaD
Nateglinide—PPARG—heart—coronary artery disease	9.6e-05	0.0224	CbGeAlD
Nateglinide—PPARG—cardiovascular system—coronary artery disease	9.06e-05	0.0212	CbGeAlD
Nateglinide—ALB—heart—coronary artery disease	9.01e-05	0.021	CbGeAlD
Nateglinide—ABCC4—heart—coronary artery disease	8.72e-05	0.0204	CbGeAlD
Nateglinide—ORM1—blood—coronary artery disease	7.66e-05	0.0179	CbGeAlD
Nateglinide—SLC15A2—heart—coronary artery disease	7.52e-05	0.0176	CbGeAlD
Nateglinide—PTGS1—myocardium—coronary artery disease	7.35e-05	0.0172	CbGeAlD
Nateglinide—PPARG—blood—coronary artery disease	7.16e-05	0.0167	CbGeAlD
Nateglinide—ABCC4—blood—coronary artery disease	6.51e-05	0.0152	CbGeAlD
Nateglinide—CYP2C9—heart—coronary artery disease	5.62e-05	0.0131	CbGeAlD
Nateglinide—SLC15A2—blood—coronary artery disease	5.61e-05	0.0131	CbGeAlD
Nateglinide—Spirapril—ACE—coronary artery disease	5.43e-05	0.0467	CrCbGaD
Nateglinide—CYP2C9—cardiovascular system—coronary artery disease	5.31e-05	0.0124	CbGeAlD
Nateglinide—Mitiglinide—PPARG—coronary artery disease	5.18e-05	0.0446	CrCbGaD
Nateglinide—PTGS1—heart—coronary artery disease	5.13e-05	0.012	CbGeAlD
Nateglinide—PTGS1—cardiovascular system—coronary artery disease	4.84e-05	0.0113	CbGeAlD
Nateglinide—Lisinopril—ACE—coronary artery disease	4.84e-05	0.0416	CrCbGaD
Nateglinide—Cilazapril—ACE—coronary artery disease	4.84e-05	0.0416	CrCbGaD
Nateglinide—Trandolapril—ACE—coronary artery disease	4.68e-05	0.0403	CrCbGaD
Nateglinide—Ramipril—ACE—coronary artery disease	4.68e-05	0.0403	CrCbGaD
Nateglinide—PTGS1—cardiac atrium—coronary artery disease	4.39e-05	0.0102	CbGeAlD
Nateglinide—CYP3A5—blood—coronary artery disease	4.26e-05	0.00995	CbGeAlD
Nateglinide—Amphetamine—SLC22A3—coronary artery disease	4.23e-05	0.0363	CrCbGaD
Nateglinide—CYP2C9—blood—coronary artery disease	4.2e-05	0.0098	CbGeAlD
Nateglinide—Methamphetamine—SLC22A3—coronary artery disease	3.92e-05	0.0337	CrCbGaD
Nateglinide—Gastrointestinal pain—Olmesartan—coronary artery disease	3.87e-05	0.00107	CcSEcCtD
Nateglinide—Asthenia—Lovastatin—coronary artery disease	3.87e-05	0.00107	CcSEcCtD
Nateglinide—Hyperhidrosis—Furosemide—coronary artery disease	3.86e-05	0.00107	CcSEcCtD
Nateglinide—Pruritus—Clopidogrel—coronary artery disease	3.84e-05	0.00106	CcSEcCtD
Nateglinide—PTGS1—blood—coronary artery disease	3.83e-05	0.00894	CbGeAlD
Nateglinide—Dyspepsia—Telmisartan—coronary artery disease	3.83e-05	0.00106	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Trandolapril—coronary artery disease	3.82e-05	0.00106	CcSEcCtD
Nateglinide—Fatigue—Trandolapril—coronary artery disease	3.82e-05	0.00106	CcSEcCtD
Nateglinide—Pruritus—Lovastatin—coronary artery disease	3.81e-05	0.00105	CcSEcCtD
Nateglinide—Fatigue—Enalapril—coronary artery disease	3.8e-05	0.00105	CcSEcCtD
Nateglinide—Asthenia—Ezetimibe—coronary artery disease	3.79e-05	0.00105	CcSEcCtD
Nateglinide—Tremor—Ramipril—coronary artery disease	3.79e-05	0.00105	CcSEcCtD
Nateglinide—Gastrointestinal pain—Niacin—coronary artery disease	3.78e-05	0.00105	CcSEcCtD
Nateglinide—Urticaria—Valsartan—coronary artery disease	3.78e-05	0.00105	CcSEcCtD
Nateglinide—Nausea—Rosuvastatin—coronary artery disease	3.78e-05	0.00105	CcSEcCtD
Nateglinide—Diarrhoea—Fenofibrate—coronary artery disease	3.78e-05	0.00104	CcSEcCtD
Nateglinide—Urticaria—Olmesartan—coronary artery disease	3.76e-05	0.00104	CcSEcCtD
Nateglinide—Abdominal pain—Valsartan—coronary artery disease	3.76e-05	0.00104	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Telmisartan—coronary artery disease	3.75e-05	0.00104	CcSEcCtD
Nateglinide—Fatigue—Telmisartan—coronary artery disease	3.75e-05	0.00104	CcSEcCtD
Nateglinide—Abdominal pain—Olmesartan—coronary artery disease	3.75e-05	0.00104	CcSEcCtD
Nateglinide—Pruritus—Ezetimibe—coronary artery disease	3.74e-05	0.00103	CcSEcCtD
Nateglinide—Gastrointestinal pain—Pravastatin—coronary artery disease	3.73e-05	0.00103	CcSEcCtD
Nateglinide—Hyperhidrosis—Losartan—coronary artery disease	3.72e-05	0.00103	CcSEcCtD
Nateglinide—Dyspepsia—Captopril—coronary artery disease	3.72e-05	0.00103	CcSEcCtD
Nateglinide—Hypersensitivity—Simvastatin—coronary artery disease	3.71e-05	0.00103	CcSEcCtD
Nateglinide—Diarrhoea—Clopidogrel—coronary artery disease	3.71e-05	0.00103	CcSEcCtD
Nateglinide—Asthenia—Eplerenone—coronary artery disease	3.71e-05	0.00103	CcSEcCtD
Nateglinide—Diarrhoea—Lovastatin—coronary artery disease	3.69e-05	0.00102	CcSEcCtD
Nateglinide—Urticaria—Niacin—coronary artery disease	3.68e-05	0.00102	CcSEcCtD
Nateglinide—Nausea—Acetylsalicylic acid—coronary artery disease	3.67e-05	0.00102	CcSEcCtD
Nateglinide—Malnutrition—Lisinopril—coronary artery disease	3.67e-05	0.00101	CcSEcCtD
Nateglinide—Pruritus—Eplerenone—coronary artery disease	3.66e-05	0.00101	CcSEcCtD
Nateglinide—Abdominal pain—Niacin—coronary artery disease	3.66e-05	0.00101	CcSEcCtD
Nateglinide—Dizziness—Fenofibrate—coronary artery disease	3.65e-05	0.00101	CcSEcCtD
Nateglinide—Fatigue—Captopril—coronary artery disease	3.64e-05	0.00101	CcSEcCtD
Nateglinide—Urticaria—Pravastatin—coronary artery disease	3.62e-05	0.001	CcSEcCtD
Nateglinide—Gastrointestinal pain—Trandolapril—coronary artery disease	3.62e-05	0.001	CcSEcCtD
Nateglinide—Asthenia—Simvastatin—coronary artery disease	3.62e-05	0.001	CcSEcCtD
Nateglinide—Diarrhoea—Ezetimibe—coronary artery disease	3.62e-05	0.001	CcSEcCtD
Nateglinide—Dyspepsia—Perindopril—coronary artery disease	3.61e-05	0.001	CcSEcCtD
Nateglinide—Gastrointestinal pain—Enalapril—coronary artery disease	3.6e-05	0.000997	CcSEcCtD
Nateglinide—Abdominal pain—Pravastatin—coronary artery disease	3.6e-05	0.000997	CcSEcCtD
Nateglinide—Dizziness—Clopidogrel—coronary artery disease	3.59e-05	0.000993	CcSEcCtD
Nateglinide—Palpitations—Ramipril—coronary artery disease	3.57e-05	0.000989	CcSEcCtD
Nateglinide—Pruritus—Simvastatin—coronary artery disease	3.57e-05	0.000987	CcSEcCtD
Nateglinide—Dizziness—Lovastatin—coronary artery disease	3.56e-05	0.000986	CcSEcCtD
Nateglinide—Gastrointestinal pain—Telmisartan—coronary artery disease	3.56e-05	0.000984	CcSEcCtD
Nateglinide—Enalapril—ACE—coronary artery disease	3.55e-05	0.0305	CrCbGaD
Nateglinide—Back pain—Lisinopril—coronary artery disease	3.55e-05	0.000982	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Perindopril—coronary artery disease	3.54e-05	0.00098	CcSEcCtD
Nateglinide—Diarrhoea—Eplerenone—coronary artery disease	3.54e-05	0.000979	CcSEcCtD
Nateglinide—Fatigue—Perindopril—coronary artery disease	3.54e-05	0.000979	CcSEcCtD
Nateglinide—Cough—Ramipril—coronary artery disease	3.53e-05	0.000977	CcSEcCtD
Nateglinide—Urticaria—Trandolapril—coronary artery disease	3.52e-05	0.000973	CcSEcCtD
Nateglinide—Vomiting—Fenofibrate—coronary artery disease	3.51e-05	0.000971	CcSEcCtD
Nateglinide—Hypersensitivity—Valsartan—coronary artery disease	3.51e-05	0.00097	CcSEcCtD
Nateglinide—Urticaria—Enalapril—coronary artery disease	3.5e-05	0.000969	CcSEcCtD
Nateglinide—Abdominal pain—Trandolapril—coronary artery disease	3.5e-05	0.000968	CcSEcCtD
Nateglinide—Dizziness—Ezetimibe—coronary artery disease	3.5e-05	0.000967	CcSEcCtD
Nateglinide—Palpitations—Timolol—coronary artery disease	3.49e-05	0.000967	CcSEcCtD
Nateglinide—Bortezomib—CYP2C19—coronary artery disease	3.49e-05	0.03	CrCbGaD
Nateglinide—Abdominal pain—Enalapril—coronary artery disease	3.48e-05	0.000964	CcSEcCtD
Nateglinide—Rash—Fenofibrate—coronary artery disease	3.48e-05	0.000963	CcSEcCtD
Nateglinide—Dermatitis—Fenofibrate—coronary artery disease	3.48e-05	0.000962	CcSEcCtD
Nateglinide—Gastrointestinal pain—Captopril—coronary artery disease	3.46e-05	0.000956	CcSEcCtD
Nateglinide—Urticaria—Telmisartan—coronary artery disease	3.45e-05	0.000956	CcSEcCtD
Nateglinide—Cough—Timolol—coronary artery disease	3.45e-05	0.000955	CcSEcCtD
Nateglinide—Vomiting—Clopidogrel—coronary artery disease	3.45e-05	0.000954	CcSEcCtD
Nateglinide—Diarrhoea—Simvastatin—coronary artery disease	3.45e-05	0.000954	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Furosemide—coronary artery disease	3.45e-05	0.000953	CcSEcCtD
Nateglinide—Fatigue—Furosemide—coronary artery disease	3.44e-05	0.000952	CcSEcCtD
Nateglinide—Tremor—Lisinopril—coronary artery disease	3.44e-05	0.000951	CcSEcCtD
Nateglinide—Abdominal pain—Telmisartan—coronary artery disease	3.44e-05	0.000951	CcSEcCtD
Nateglinide—Vomiting—Lovastatin—coronary artery disease	3.43e-05	0.000948	CcSEcCtD
Nateglinide—Dizziness—Eplerenone—coronary artery disease	3.42e-05	0.000947	CcSEcCtD
Nateglinide—Rash—Clopidogrel—coronary artery disease	3.42e-05	0.000946	CcSEcCtD
Nateglinide—Dermatitis—Clopidogrel—coronary artery disease	3.42e-05	0.000946	CcSEcCtD
Nateglinide—Asthenia—Valsartan—coronary artery disease	3.42e-05	0.000945	CcSEcCtD
Nateglinide—Hypersensitivity—Niacin—coronary artery disease	3.41e-05	0.000943	CcSEcCtD
Nateglinide—Asthenia—Olmesartan—coronary artery disease	3.4e-05	0.00094	CcSEcCtD
Nateglinide—Rash—Lovastatin—coronary artery disease	3.4e-05	0.00094	CcSEcCtD
Nateglinide—Dermatitis—Lovastatin—coronary artery disease	3.39e-05	0.000939	CcSEcCtD
Nateglinide—Dyspepsia—Losartan—coronary artery disease	3.39e-05	0.000938	CcSEcCtD
Nateglinide—Pruritus—Valsartan—coronary artery disease	3.37e-05	0.000932	CcSEcCtD
Nateglinide—Vomiting—Ezetimibe—coronary artery disease	3.36e-05	0.00093	CcSEcCtD
Nateglinide—Hypersensitivity—Pravastatin—coronary artery disease	3.36e-05	0.000929	CcSEcCtD
Nateglinide—Gastrointestinal pain—Perindopril—coronary artery disease	3.36e-05	0.000929	CcSEcCtD
Nateglinide—Pruritus—Olmesartan—coronary artery disease	3.35e-05	0.000927	CcSEcCtD
Nateglinide—Abdominal pain—Captopril—coronary artery disease	3.34e-05	0.000925	CcSEcCtD
Nateglinide—Dizziness—Simvastatin—coronary artery disease	3.33e-05	0.000922	CcSEcCtD
Nateglinide—Rash—Ezetimibe—coronary artery disease	3.33e-05	0.000922	CcSEcCtD
Nateglinide—Dermatitis—Ezetimibe—coronary artery disease	3.33e-05	0.000921	CcSEcCtD
Nateglinide—Asthenia—Niacin—coronary artery disease	3.32e-05	0.000919	CcSEcCtD
Nateglinide—Fatigue—Losartan—coronary artery disease	3.32e-05	0.000918	CcSEcCtD
Nateglinide—Vomiting—Eplerenone—coronary artery disease	3.29e-05	0.00091	CcSEcCtD
Nateglinide—Nausea—Fenofibrate—coronary artery disease	3.28e-05	0.000907	CcSEcCtD
Nateglinide—Pruritus—Niacin—coronary artery disease	3.27e-05	0.000906	CcSEcCtD
Nateglinide—Asthenia—Pravastatin—coronary artery disease	3.27e-05	0.000905	CcSEcCtD
Nateglinide—Gastrointestinal pain—Furosemide—coronary artery disease	3.26e-05	0.000903	CcSEcCtD
Nateglinide—Rash—Eplerenone—coronary artery disease	3.26e-05	0.000903	CcSEcCtD
Nateglinide—Urticaria—Perindopril—coronary artery disease	3.26e-05	0.000902	CcSEcCtD
Nateglinide—Hypersensitivity—Trandolapril—coronary artery disease	3.26e-05	0.000902	CcSEcCtD
Nateglinide—Dermatitis—Eplerenone—coronary artery disease	3.26e-05	0.000902	CcSEcCtD
Nateglinide—Diarrhoea—Valsartan—coronary artery disease	3.26e-05	0.000901	CcSEcCtD
Nateglinide—Hypersensitivity—Enalapril—coronary artery disease	3.25e-05	0.000898	CcSEcCtD
Nateglinide—Abdominal pain—Perindopril—coronary artery disease	3.24e-05	0.000898	CcSEcCtD
Nateglinide—Palpitations—Lisinopril—coronary artery disease	3.24e-05	0.000897	CcSEcCtD
Nateglinide—Diarrhoea—Olmesartan—coronary artery disease	3.24e-05	0.000897	CcSEcCtD
Nateglinide—Pruritus—Pravastatin—coronary artery disease	3.22e-05	0.000892	CcSEcCtD
Nateglinide—Nausea—Clopidogrel—coronary artery disease	3.22e-05	0.000892	CcSEcCtD
Nateglinide—Vomiting—Simvastatin—coronary artery disease	3.21e-05	0.000887	CcSEcCtD
Nateglinide—Hypersensitivity—Telmisartan—coronary artery disease	3.2e-05	0.000886	CcSEcCtD
Nateglinide—Cough—Lisinopril—coronary artery disease	3.2e-05	0.000886	CcSEcCtD
Nateglinide—Nausea—Lovastatin—coronary artery disease	3.2e-05	0.000886	CcSEcCtD
Nateglinide—CYP3A4—blood—coronary artery disease	3.2e-05	0.00747	CbGeAlD
Nateglinide—Hyperhidrosis—Ramipril—coronary artery disease	3.19e-05	0.000883	CcSEcCtD
Nateglinide—Rash—Simvastatin—coronary artery disease	3.18e-05	0.000879	CcSEcCtD
Nateglinide—Dermatitis—Simvastatin—coronary artery disease	3.18e-05	0.000879	CcSEcCtD
Nateglinide—Asthenia—Trandolapril—coronary artery disease	3.18e-05	0.000878	CcSEcCtD
Nateglinide—Urticaria—Furosemide—coronary artery disease	3.17e-05	0.000877	CcSEcCtD
Nateglinide—Diarrhoea—Niacin—coronary artery disease	3.17e-05	0.000876	CcSEcCtD
Nateglinide—Asthenia—Enalapril—coronary artery disease	3.16e-05	0.000875	CcSEcCtD
Nateglinide—Abdominal pain—Furosemide—coronary artery disease	3.15e-05	0.000873	CcSEcCtD
Nateglinide—Gastrointestinal pain—Losartan—coronary artery disease	3.15e-05	0.000871	CcSEcCtD
Nateglinide—CYP2D6—blood—coronary artery disease	3.15e-05	0.00735	CbGeAlD
Nateglinide—Dizziness—Valsartan—coronary artery disease	3.15e-05	0.000871	CcSEcCtD
Nateglinide—Nausea—Ezetimibe—coronary artery disease	3.14e-05	0.000869	CcSEcCtD
Nateglinide—Dizziness—Olmesartan—coronary artery disease	3.13e-05	0.000867	CcSEcCtD
Nateglinide—Pruritus—Trandolapril—coronary artery disease	3.13e-05	0.000866	CcSEcCtD
Nateglinide—Hyperhidrosis—Timolol—coronary artery disease	3.12e-05	0.000863	CcSEcCtD
Nateglinide—Asthenia—Telmisartan—coronary artery disease	3.12e-05	0.000863	CcSEcCtD
Nateglinide—Pruritus—Enalapril—coronary artery disease	3.12e-05	0.000863	CcSEcCtD
Nateglinide—Diarrhoea—Pravastatin—coronary artery disease	3.12e-05	0.000863	CcSEcCtD
Nateglinide—Pruritus—Telmisartan—coronary artery disease	3.08e-05	0.000851	CcSEcCtD
Nateglinide—Nausea—Eplerenone—coronary artery disease	3.07e-05	0.00085	CcSEcCtD
Nateglinide—Dizziness—Niacin—coronary artery disease	3.06e-05	0.000847	CcSEcCtD
Nateglinide—Urticaria—Losartan—coronary artery disease	3.06e-05	0.000846	CcSEcCtD
Nateglinide—Abdominal pain—Losartan—coronary artery disease	3.04e-05	0.000842	CcSEcCtD
Nateglinide—Asthenia—Captopril—coronary artery disease	3.03e-05	0.000839	CcSEcCtD
Nateglinide—Diarrhoea—Trandolapril—coronary artery disease	3.03e-05	0.000838	CcSEcCtD
Nateglinide—Vomiting—Valsartan—coronary artery disease	3.03e-05	0.000837	CcSEcCtD
Nateglinide—Diarrhoea—Enalapril—coronary artery disease	3.02e-05	0.000834	CcSEcCtD
Nateglinide—Dizziness—Pravastatin—coronary artery disease	3.01e-05	0.000834	CcSEcCtD
Nateglinide—Vomiting—Olmesartan—coronary artery disease	3.01e-05	0.000833	CcSEcCtD
Nateglinide—Rash—Valsartan—coronary artery disease	3e-05	0.00083	CcSEcCtD
Nateglinide—Dermatitis—Valsartan—coronary artery disease	3e-05	0.00083	CcSEcCtD
Nateglinide—Nausea—Simvastatin—coronary artery disease	2.99e-05	0.000828	CcSEcCtD
Nateglinide—Pruritus—Captopril—coronary artery disease	2.99e-05	0.000828	CcSEcCtD
Nateglinide—Rash—Olmesartan—coronary artery disease	2.99e-05	0.000826	CcSEcCtD
Nateglinide—Dermatitis—Olmesartan—coronary artery disease	2.98e-05	0.000826	CcSEcCtD
Nateglinide—Diarrhoea—Telmisartan—coronary artery disease	2.97e-05	0.000823	CcSEcCtD
Nateglinide—Asthenia—Perindopril—coronary artery disease	2.95e-05	0.000815	CcSEcCtD
Nateglinide—Vomiting—Niacin—coronary artery disease	2.94e-05	0.000814	CcSEcCtD
Nateglinide—Hypersensitivity—Furosemide—coronary artery disease	2.94e-05	0.000813	CcSEcCtD
Nateglinide—Dizziness—Trandolapril—coronary artery disease	2.93e-05	0.00081	CcSEcCtD
Nateglinide—Rash—Niacin—coronary artery disease	2.92e-05	0.000807	CcSEcCtD
Nateglinide—Dermatitis—Niacin—coronary artery disease	2.92e-05	0.000807	CcSEcCtD
Nateglinide—Dizziness—Enalapril—coronary artery disease	2.91e-05	0.000806	CcSEcCtD
Nateglinide—Dyspepsia—Ramipril—coronary artery disease	2.91e-05	0.000804	CcSEcCtD
Nateglinide—Pruritus—Perindopril—coronary artery disease	2.9e-05	0.000803	CcSEcCtD
Nateglinide—Vomiting—Pravastatin—coronary artery disease	2.9e-05	0.000802	CcSEcCtD
Nateglinide—Hyperhidrosis—Lisinopril—coronary artery disease	2.89e-05	0.000801	CcSEcCtD
Nateglinide—Diarrhoea—Captopril—coronary artery disease	2.89e-05	0.0008	CcSEcCtD
Nateglinide—Dizziness—Telmisartan—coronary artery disease	2.88e-05	0.000795	CcSEcCtD
Nateglinide—Rash—Pravastatin—coronary artery disease	2.87e-05	0.000795	CcSEcCtD
Nateglinide—Dermatitis—Pravastatin—coronary artery disease	2.87e-05	0.000794	CcSEcCtD
Nateglinide—Asthenia—Furosemide—coronary artery disease	2.86e-05	0.000792	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Ramipril—coronary artery disease	2.85e-05	0.000789	CcSEcCtD
Nateglinide—Fatigue—Ramipril—coronary artery disease	2.85e-05	0.000787	CcSEcCtD
Nateglinide—Dyspepsia—Timolol—coronary artery disease	2.84e-05	0.000786	CcSEcCtD
Nateglinide—Hypersensitivity—Losartan—coronary artery disease	2.84e-05	0.000785	CcSEcCtD
Nateglinide—Nausea—Valsartan—coronary artery disease	2.83e-05	0.000782	CcSEcCtD
Nateglinide—Pruritus—Furosemide—coronary artery disease	2.82e-05	0.000781	CcSEcCtD
Nateglinide—Nausea—Olmesartan—coronary artery disease	2.81e-05	0.000779	CcSEcCtD
Nateglinide—Vomiting—Trandolapril—coronary artery disease	2.81e-05	0.000778	CcSEcCtD
Nateglinide—Diarrhoea—Perindopril—coronary artery disease	2.81e-05	0.000777	CcSEcCtD
Nateglinide—Vomiting—Enalapril—coronary artery disease	2.8e-05	0.000775	CcSEcCtD
Nateglinide—Dizziness—Captopril—coronary artery disease	2.8e-05	0.000773	CcSEcCtD
Nateglinide—Rash—Trandolapril—coronary artery disease	2.79e-05	0.000772	CcSEcCtD
Nateglinide—Dermatitis—Trandolapril—coronary artery disease	2.79e-05	0.000771	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Timolol—coronary artery disease	2.79e-05	0.000771	CcSEcCtD
Nateglinide—Fatigue—Timolol—coronary artery disease	2.78e-05	0.00077	CcSEcCtD
Nateglinide—Rash—Enalapril—coronary artery disease	2.78e-05	0.000769	CcSEcCtD
Nateglinide—Dermatitis—Enalapril—coronary artery disease	2.78e-05	0.000768	CcSEcCtD
Nateglinide—Vomiting—Telmisartan—coronary artery disease	2.76e-05	0.000765	CcSEcCtD
Nateglinide—Asthenia—Losartan—coronary artery disease	2.76e-05	0.000764	CcSEcCtD
Nateglinide—Nausea—Niacin—coronary artery disease	2.75e-05	0.000761	CcSEcCtD
Nateglinide—Rash—Telmisartan—coronary artery disease	2.74e-05	0.000758	CcSEcCtD
Nateglinide—Dermatitis—Telmisartan—coronary artery disease	2.74e-05	0.000758	CcSEcCtD
Nateglinide—Diarrhoea—Furosemide—coronary artery disease	2.73e-05	0.000755	CcSEcCtD
Nateglinide—Pruritus—Losartan—coronary artery disease	2.72e-05	0.000754	CcSEcCtD
Nateglinide—Dizziness—Perindopril—coronary artery disease	2.71e-05	0.000751	CcSEcCtD
Nateglinide—Nausea—Pravastatin—coronary artery disease	2.71e-05	0.000749	CcSEcCtD
Nateglinide—Gastrointestinal pain—Ramipril—coronary artery disease	2.7e-05	0.000747	CcSEcCtD
Nateglinide—Vomiting—Captopril—coronary artery disease	2.69e-05	0.000744	CcSEcCtD
Nateglinide—Rash—Captopril—coronary artery disease	2.67e-05	0.000737	CcSEcCtD
Nateglinide—Dermatitis—Captopril—coronary artery disease	2.66e-05	0.000737	CcSEcCtD
Nateglinide—Gastrointestinal pain—Timolol—coronary artery disease	2.64e-05	0.00073	CcSEcCtD
Nateglinide—Dizziness—Furosemide—coronary artery disease	2.64e-05	0.00073	CcSEcCtD
Nateglinide—Dyspepsia—Lisinopril—coronary artery disease	2.64e-05	0.000729	CcSEcCtD
Nateglinide—Diarrhoea—Losartan—coronary artery disease	2.63e-05	0.000729	CcSEcCtD
Nateglinide—Nausea—Trandolapril—coronary artery disease	2.63e-05	0.000727	CcSEcCtD
Nateglinide—Urticaria—Ramipril—coronary artery disease	2.62e-05	0.000726	CcSEcCtD
Nateglinide—Nausea—Enalapril—coronary artery disease	2.62e-05	0.000724	CcSEcCtD
Nateglinide—Vomiting—Perindopril—coronary artery disease	2.61e-05	0.000722	CcSEcCtD
Nateglinide—Abdominal pain—Ramipril—coronary artery disease	2.61e-05	0.000722	CcSEcCtD
Nateglinide—Rash—Perindopril—coronary artery disease	2.59e-05	0.000716	CcSEcCtD
Nateglinide—Dermatitis—Perindopril—coronary artery disease	2.59e-05	0.000715	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.58e-05	0.000715	CcSEcCtD
Nateglinide—Nausea—Telmisartan—coronary artery disease	2.58e-05	0.000714	CcSEcCtD
Nateglinide—Fatigue—Lisinopril—coronary artery disease	2.58e-05	0.000714	CcSEcCtD
Nateglinide—Urticaria—Timolol—coronary artery disease	2.56e-05	0.000709	CcSEcCtD
Nateglinide—Abdominal pain—Timolol—coronary artery disease	2.55e-05	0.000706	CcSEcCtD
Nateglinide—Dizziness—Losartan—coronary artery disease	2.55e-05	0.000704	CcSEcCtD
Nateglinide—Vomiting—Furosemide—coronary artery disease	2.54e-05	0.000702	CcSEcCtD
Nateglinide—Rash—Furosemide—coronary artery disease	2.52e-05	0.000696	CcSEcCtD
Nateglinide—Dermatitis—Furosemide—coronary artery disease	2.51e-05	0.000695	CcSEcCtD
Nateglinide—Nausea—Captopril—coronary artery disease	2.51e-05	0.000695	CcSEcCtD
Nateglinide—Gastrointestinal pain—Lisinopril—coronary artery disease	2.45e-05	0.000677	CcSEcCtD
Nateglinide—Vomiting—Losartan—coronary artery disease	2.45e-05	0.000677	CcSEcCtD
Nateglinide—Nausea—Perindopril—coronary artery disease	2.44e-05	0.000675	CcSEcCtD
Nateglinide—Hypersensitivity—Ramipril—coronary artery disease	2.43e-05	0.000673	CcSEcCtD
Nateglinide—Rash—Losartan—coronary artery disease	2.43e-05	0.000672	CcSEcCtD
Nateglinide—Dermatitis—Losartan—coronary artery disease	2.43e-05	0.000671	CcSEcCtD
Nateglinide—Urticaria—Lisinopril—coronary artery disease	2.38e-05	0.000658	CcSEcCtD
Nateglinide—Hypersensitivity—Timolol—coronary artery disease	2.38e-05	0.000658	CcSEcCtD
Nateglinide—Nausea—Furosemide—coronary artery disease	2.37e-05	0.000656	CcSEcCtD
Nateglinide—Asthenia—Ramipril—coronary artery disease	2.37e-05	0.000655	CcSEcCtD
Nateglinide—Abdominal pain—Lisinopril—coronary artery disease	2.37e-05	0.000655	CcSEcCtD
Nateglinide—Pruritus—Ramipril—coronary artery disease	2.34e-05	0.000646	CcSEcCtD
Nateglinide—Asthenia—Timolol—coronary artery disease	2.32e-05	0.000641	CcSEcCtD
Nateglinide—Nausea—Losartan—coronary artery disease	2.29e-05	0.000633	CcSEcCtD
Nateglinide—Pruritus—Timolol—coronary artery disease	2.28e-05	0.000632	CcSEcCtD
Nateglinide—Diarrhoea—Ramipril—coronary artery disease	2.26e-05	0.000625	CcSEcCtD
Nateglinide—Diarrhoea—Timolol—coronary artery disease	2.21e-05	0.000611	CcSEcCtD
Nateglinide—Hypersensitivity—Lisinopril—coronary artery disease	2.21e-05	0.00061	CcSEcCtD
Nateglinide—Dizziness—Ramipril—coronary artery disease	2.18e-05	0.000604	CcSEcCtD
Nateglinide—Asthenia—Lisinopril—coronary artery disease	2.15e-05	0.000594	CcSEcCtD
Nateglinide—Dizziness—Timolol—coronary artery disease	2.13e-05	0.00059	CcSEcCtD
Nateglinide—Pruritus—Lisinopril—coronary artery disease	2.12e-05	0.000586	CcSEcCtD
Nateglinide—Vomiting—Ramipril—coronary artery disease	2.1e-05	0.000581	CcSEcCtD
Nateglinide—Rash—Ramipril—coronary artery disease	2.08e-05	0.000576	CcSEcCtD
Nateglinide—Dermatitis—Ramipril—coronary artery disease	2.08e-05	0.000575	CcSEcCtD
Nateglinide—Vomiting—Timolol—coronary artery disease	2.05e-05	0.000568	CcSEcCtD
Nateglinide—Diarrhoea—Lisinopril—coronary artery disease	2.05e-05	0.000567	CcSEcCtD
Nateglinide—Rash—Timolol—coronary artery disease	2.03e-05	0.000563	CcSEcCtD
Nateglinide—Dermatitis—Timolol—coronary artery disease	2.03e-05	0.000562	CcSEcCtD
Nateglinide—Dizziness—Lisinopril—coronary artery disease	1.98e-05	0.000548	CcSEcCtD
Nateglinide—Nausea—Ramipril—coronary artery disease	1.96e-05	0.000543	CcSEcCtD
Nateglinide—Nausea—Timolol—coronary artery disease	1.92e-05	0.00053	CcSEcCtD
Nateglinide—Vomiting—Lisinopril—coronary artery disease	1.9e-05	0.000527	CcSEcCtD
Nateglinide—Rash—Lisinopril—coronary artery disease	1.89e-05	0.000522	CcSEcCtD
Nateglinide—Dermatitis—Lisinopril—coronary artery disease	1.89e-05	0.000522	CcSEcCtD
Nateglinide—Nausea—Lisinopril—coronary artery disease	1.78e-05	0.000492	CcSEcCtD
Nateglinide—PPARG—Metabolism—NOS3—coronary artery disease	7.68e-07	2.7e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—coronary artery disease	7.67e-07	2.7e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDH2—coronary artery disease	7.64e-07	2.68e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LCAT—coronary artery disease	7.6e-07	2.67e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CPT1B—coronary artery disease	7.6e-07	2.67e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	7.6e-07	2.67e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDH2—coronary artery disease	7.57e-07	2.66e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—coronary artery disease	7.57e-07	2.66e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AGT—coronary artery disease	7.56e-07	2.66e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA4—coronary artery disease	7.46e-07	2.62e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LIPC—coronary artery disease	7.45e-07	2.62e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	7.45e-07	2.62e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HBA1—coronary artery disease	7.45e-07	2.62e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2C19—coronary artery disease	7.45e-07	2.62e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—coronary artery disease	7.41e-07	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOC3—coronary artery disease	7.4e-07	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.38e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LIPC—coronary artery disease	7.38e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HBA1—coronary artery disease	7.38e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	7.38e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	7.38e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LDLR—coronary artery disease	7.35e-07	2.58e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOC3—coronary artery disease	7.34e-07	2.58e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AGT—coronary artery disease	7.33e-07	2.57e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOA1—coronary artery disease	7.32e-07	2.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LDLR—coronary artery disease	7.29e-07	2.56e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.28e-07	2.56e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—coronary artery disease	7.27e-07	2.55e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC9A1—coronary artery disease	7.27e-07	2.55e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLCB1—coronary artery disease	7.24e-07	2.54e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PDHA1—coronary artery disease	7.21e-07	2.53e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCLM—coronary artery disease	7.21e-07	2.53e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—coronary artery disease	7.2e-07	2.53e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	7.2e-07	2.53e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCLC—coronary artery disease	7.18e-07	2.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CETP—coronary artery disease	7.18e-07	2.52e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—coronary artery disease	7.18e-07	2.52e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCLC—coronary artery disease	7.12e-07	2.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CETP—coronary artery disease	7.12e-07	2.5e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SDC1—coronary artery disease	7.1e-07	2.49e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOA1—coronary artery disease	7.1e-07	2.49e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.1e-07	2.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—coronary artery disease	7.08e-07	2.49e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SDC1—coronary artery disease	7.04e-07	2.47e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—coronary artery disease	7.03e-07	2.47e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	7.02e-07	2.47e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCA1—coronary artery disease	7.01e-07	2.46e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—coronary artery disease	6.99e-07	2.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.98e-07	2.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.98e-07	2.45e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—coronary artery disease	6.9e-07	2.42e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAT—coronary artery disease	6.89e-07	2.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.88e-07	2.41e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.8e-07	2.39e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GGT1—coronary artery disease	6.79e-07	2.39e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GOT1—coronary artery disease	6.79e-07	2.39e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.78e-07	2.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HADH—coronary artery disease	6.78e-07	2.38e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PSMB5—coronary artery disease	6.71e-07	2.36e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PSMA6—coronary artery disease	6.71e-07	2.36e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOB—coronary artery disease	6.69e-07	2.35e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PSMA6—coronary artery disease	6.65e-07	2.34e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PSMB5—coronary artery disease	6.65e-07	2.34e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.64e-07	2.33e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—coronary artery disease	6.6e-07	2.32e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CTGF—coronary artery disease	6.56e-07	2.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—coronary artery disease	6.51e-07	2.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CTGF—coronary artery disease	6.5e-07	2.28e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMGCR—coronary artery disease	6.5e-07	2.28e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT2—coronary artery disease	6.5e-07	2.28e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—coronary artery disease	6.45e-07	2.27e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMGCR—coronary artery disease	6.44e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT2—coronary artery disease	6.44e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX2—coronary artery disease	6.42e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.42e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA2—coronary artery disease	6.42e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LPL—coronary artery disease	6.39e-07	2.24e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—coronary artery disease	6.37e-07	2.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.34e-07	2.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HK1—coronary artery disease	6.34e-07	2.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX4—coronary artery disease	6.34e-07	2.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.34e-07	2.23e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HADHA—coronary artery disease	6.27e-07	2.2e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—coronary artery disease	6.26e-07	2.2e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—coronary artery disease	6.23e-07	2.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.2e-07	2.18e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—coronary artery disease	6.17e-07	2.17e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—coronary artery disease	6.14e-07	2.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPA—coronary artery disease	6.13e-07	2.15e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—coronary artery disease	6.1e-07	2.14e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD36—coronary artery disease	6.07e-07	2.13e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARGC1A—coronary artery disease	6.04e-07	2.12e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—coronary artery disease	6.04e-07	2.12e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—coronary artery disease	6.03e-07	2.12e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—coronary artery disease	6.02e-07	2.11e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPP2CA—coronary artery disease	6e-07	2.11e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.97e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAT—coronary artery disease	5.94e-07	2.09e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.93e-07	2.08e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.92e-07	2.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA5—coronary artery disease	5.87e-07	2.06e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—coronary artery disease	5.85e-07	2.05e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.81e-07	2.04e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—coronary artery disease	5.8e-07	2.04e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.79e-07	2.03e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—coronary artery disease	5.76e-07	2.02e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOB—coronary artery disease	5.76e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—P4HB—coronary artery disease	5.76e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—coronary artery disease	5.75e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCA1—coronary artery disease	5.74e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.66e-07	1.99e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—coronary artery disease	5.64e-07	1.98e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—coronary artery disease	5.63e-07	1.98e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT1—coronary artery disease	5.61e-07	1.97e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GGT1—coronary artery disease	5.61e-07	1.97e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—coronary artery disease	5.61e-07	1.97e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT1—coronary artery disease	5.56e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GGT1—coronary artery disease	5.56e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—coronary artery disease	5.55e-07	1.95e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK1—coronary artery disease	5.53e-07	1.94e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LPL—coronary artery disease	5.5e-07	1.93e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—coronary artery disease	5.47e-07	1.92e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—coronary artery disease	5.38e-07	1.89e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—coronary artery disease	5.37e-07	1.89e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—coronary artery disease	5.36e-07	1.88e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—VCAN—coronary artery disease	5.33e-07	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOA1—coronary artery disease	5.29e-07	1.86e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.29e-07	1.86e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD36—coronary artery disease	5.23e-07	1.84e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPP2CA—coronary artery disease	5.16e-07	1.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DCN—coronary artery disease	5.14e-07	1.8e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—coronary artery disease	5.08e-07	1.78e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.04e-07	1.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDH2—coronary artery disease	5e-07	1.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.99e-07	1.75e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.99e-07	1.75e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.97e-07	1.74e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—coronary artery disease	4.95e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.95e-07	1.74e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—coronary artery disease	4.93e-07	1.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.92e-07	1.73e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—coronary artery disease	4.92e-07	1.73e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAT—coronary artery disease	4.9e-07	1.72e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.87e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LIPC—coronary artery disease	4.87e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.87e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HBA1—coronary artery disease	4.87e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAT—coronary artery disease	4.86e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOC3—coronary artery disease	4.84e-07	1.7e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LDLR—coronary artery disease	4.81e-07	1.69e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—coronary artery disease	4.8e-07	1.68e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—coronary artery disease	4.78e-07	1.68e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOB—coronary artery disease	4.76e-07	1.67e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.75e-07	1.67e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.75e-07	1.67e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOB—coronary artery disease	4.72e-07	1.66e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—coronary artery disease	4.71e-07	1.65e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—coronary artery disease	4.71e-07	1.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCLC—coronary artery disease	4.7e-07	1.65e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CETP—coronary artery disease	4.7e-07	1.65e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—coronary artery disease	4.67e-07	1.64e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SDC1—coronary artery disease	4.64e-07	1.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.63e-07	1.63e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—coronary artery disease	4.61e-07	1.62e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—coronary artery disease	4.6e-07	1.62e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.59e-07	1.61e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOA1—coronary artery disease	4.56e-07	1.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LPL—coronary artery disease	4.54e-07	1.6e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—coronary artery disease	4.54e-07	1.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LPL—coronary artery disease	4.5e-07	1.58e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—coronary artery disease	4.43e-07	1.56e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—coronary artery disease	4.39e-07	1.54e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.39e-07	1.54e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.39e-07	1.54e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.37e-07	1.53e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—coronary artery disease	4.32e-07	1.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD36—coronary artery disease	4.32e-07	1.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CTGF—coronary artery disease	4.29e-07	1.51e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD36—coronary artery disease	4.28e-07	1.5e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.26e-07	1.5e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT2—coronary artery disease	4.25e-07	1.49e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.25e-07	1.49e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	4.23e-07	1.48e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—coronary artery disease	4.19e-07	1.47e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.09e-07	1.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—coronary artery disease	4.06e-07	1.42e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—coronary artery disease	4.02e-07	1.41e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—coronary artery disease	4.01e-07	1.41e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—coronary artery disease	3.96e-07	1.39e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—coronary artery disease	3.92e-07	1.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.91e-07	1.37e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—coronary artery disease	3.89e-07	1.37e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—coronary artery disease	3.85e-07	1.35e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—coronary artery disease	3.81e-07	1.34e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.79e-07	1.33e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—coronary artery disease	3.78e-07	1.33e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA1—coronary artery disease	3.76e-07	1.32e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA1—coronary artery disease	3.73e-07	1.31e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—coronary artery disease	3.71e-07	1.3e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—coronary artery disease	3.67e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GGT1—coronary artery disease	3.67e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT1—coronary artery disease	3.67e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.57e-07	1.26e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—coronary artery disease	3.53e-07	1.24e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—coronary artery disease	3.46e-07	1.21e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—coronary artery disease	3.32e-07	1.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.29e-07	1.16e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—coronary artery disease	3.29e-07	1.16e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—coronary artery disease	3.27e-07	1.15e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.26e-07	1.15e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.25e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—coronary artery disease	3.24e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAT—coronary artery disease	3.2e-07	1.13e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—coronary artery disease	3.16e-07	1.11e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—coronary artery disease	3.12e-07	1.1e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOB—coronary artery disease	3.11e-07	1.09e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—coronary artery disease	3.03e-07	1.07e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—coronary artery disease	3.03e-07	1.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.03e-07	1.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—coronary artery disease	2.98e-07	1.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPL—coronary artery disease	2.97e-07	1.04e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—coronary artery disease	2.96e-07	1.04e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—coronary artery disease	2.9e-07	1.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—coronary artery disease	2.85e-07	1e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—coronary artery disease	2.83e-07	9.94e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD36—coronary artery disease	2.82e-07	9.91e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.79e-07	9.79e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.67e-07	9.39e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.61e-07	9.17e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.59e-07	9.09e-06	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—coronary artery disease	2.55e-07	8.96e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—coronary artery disease	2.54e-07	8.93e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—coronary artery disease	2.49e-07	8.75e-06	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—coronary artery disease	2.47e-07	8.69e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA1—coronary artery disease	2.46e-07	8.65e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—coronary artery disease	2.26e-07	7.93e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—coronary artery disease	2.17e-07	7.62e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—coronary artery disease	2.14e-07	7.51e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—coronary artery disease	1.95e-07	6.85e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—coronary artery disease	1.94e-07	6.83e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—coronary artery disease	1.87e-07	6.55e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—coronary artery disease	1.84e-07	6.48e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.71e-07	5.99e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.61e-07	5.64e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.59e-07	5.59e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—coronary artery disease	1.59e-07	5.58e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—coronary artery disease	1.31e-07	4.61e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—coronary artery disease	1.3e-07	4.57e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.05e-07	3.69e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—coronary artery disease	8.58e-08	3.01e-06	CbGpPWpGaD
